For the year ending 2025-12-31, NERV has $97,968,888 in assets. $233,755,048 in debts. $82,301,813 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 82,301,813 | |||
| Restricted cash | 100,000 | |||
| Prepaid expenses and other current assets | 697,676 | |||
| Total current assets | 83,099,489 | |||
| Equipment, net | 0 | |||
| Goodwill | 14,869,399 | |||
| Total assets | 97,968,888 | |||
| Accounts payable | 639,707 | |||
| Accrued expenses and other current liabilities | 1,650,766 | |||
| Total current liabilities | 2,290,473 | |||
| Warrant liability | 171,464,575 | |||
| Liability related to the sale of future royalties | 60,000,000 | |||
| Total liabilities | 233,755,048 | |||
| Series a convertible preferred stock 0.0001 par value 200,000 shares authorized 3,296 issued and outstanding liquidation preference of 0 as of december 31, 2025 and 0 shares authorized none issued or outstanding as of december 31, 2024 | 4,961,922 | |||
| Common stock 0.0001 par value 250,000,000 shares authorized 43,274,398 shares issued and outstanding as of december 31, 2025 and 125,000,000 shares authorized 6,993,406 shares issued and outstanding as of december 31, 2024 | 4,327 | |||
| Additional paid-in capital | 548,047,331 | |||
| Accumulated deficit | -688,799,740 | |||
| Total stockholders' deficit | -140,748,082 | |||
| Total liabilities, redeemable preferred stock and stockholders' deficit | 97,968,888 | |||
Minerva Neurosciences, Inc. (NERV)
Minerva Neurosciences, Inc. (NERV)